60. Aplastic anemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 245 / Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166
Aplastic anemia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
60 | Aplastic anemia | - |
46 | Malignant rheumatoid arthritis | 27.190 |
285 | Fanconi anemia | 24.679 |
65 | Primary immunodeficiency | 24.286 |
13 | Multiple sclerosis/Neuromyelitis optica | 23.827 |
49 | Systemic lupus erythematosus | 22.307 |
96 | Crohn disease | 20.222 |
284 | Diamond-Blackfan anemia | 17.581 |
19 | Lysosomal storage disease | 13.696 |
283 | Acquired pure red cell aplasia | 13.393 |
53 | Sjogren syndrome | 13.333 |
164 | Oculocutaneous albinism | 13.160 |
97 | Ulcerative colitis | 13.136 |
51 | Scleroderma | 12.451 |
11 | Myasthenia gravis | 11.829 |
41 | Giant cell arteritis | 10.898 |
62 | Paroxysmal nocturnal hemoglobinuria | 10.889 |
45 | Eosinophilic granulomatosis with Polyangiitis | 10.507 |
55 | Relapsing polychondritis | 10.323 |
40 | Takayasu arteritis | 9.893 |
326 | Osteopetrosis | 9.857 |
63 | Idiopathic thrombocytopenic purpura | 9.617 |
85 | Idiopathic interstitial pneumonia | 9.584 |
28 | Systemic amyloidosis | 9.487 |
50 | Dermatomyositis | 9.397 |
107 | Juvenile idiopathic arthritis | 9.143 |
234 | Peroxisomal disease (except Adrenoleukodystrophy) | 8.730 |
162 | Pemphigoid | 8.626 |
228 | Bronchiolitis obliterans | 8.626 |
42 | Polyarteritis nodosa | 8.512 |
64 | Thrombotic thrombocytopenic purpura | 8.463 |
93 | Primary biliary cholangitis | 8.400 |
20 | Adrenoleukodystrophy | 8.104 |
35 | Pemphigus | 8.104 |
286 | Hereditary sideroblastic anemia | 8.000 |
222 | Primary nephrotic syndrome | 7.728 |
95 | Autoimmune hepatitis | 7.581 |
61 | Autoimmune hemolytic anemia | 7.543 |
56 | Behcet disease | 7.265 |
2 | Amyotrophic lateral sclerosis | 7.017 |
66 | IgA nephropathy | 6.367 |
39 | Toxic epidermal necrolysis | 6.234 |
38 | Stevens-Johnson syndrome | 6.171 |
224 | Purpura nephritis | 6.171 |
151 | Rasmussen encephalitis | 6.000 |
36 | Epidermolysis bullosa | 5.528 |
84 | Sarcoidosis | 5.447 |
299 | Cystic fibrosis | 5.239 |
113 | Muscular dystrophy | 5.172 |
271 | Ankylosing spondylitis | 5.059 |
302 | Leber hereditary optic neuropathy | 5.000 |
300 | IgG4-related disease | 4.978 |
269 | Pyogenic arthritis | 4.978 |
44 | Wegener granulomatosis | 4.959 |
331 | Idiopathic multicentric castleman disease | 4.839 |
6 | Parkinson disease | 4.645 |
160 | Congenital ichthyosis | 4.402 |
26 | HTLV-1-associated myelopathy | 4.386 |
226 | Interstitial cystitis with Hunners ulcer | 4.276 |
43 | Microscopic polyangiitis | 4.083 |
158 | Tuberous sclerosis | 3.747 |
274 | Osteogenesis Imperfecta | 3.061 |
227 | Osler disease | 2.942 |
270 | Chronic recurrent multifocal osteomyelitis | 2.794 |
83 | Addison disease | 2.794 |
94 | Primary sclerosing cholangitis | 2.481 |
34 | Neurofibromatosis | 2.119 |
77 | Growth hormone secreting pituitary adenoma | 2.000 |
16 | Crow-Fukase syndrome | 1.886 |
256 | Muscle glycogenosis | 1.853 |
76 | Pituitary gonadotropin secretion hyperthyroidism | 1.607 |
81 | Congenital adrenal hyperplasia | 1.587 |
14 | Chronic inflammatory demyelinating polyneuropathy | 1.587 |
86 | Pulmonary arterial hypertension | 1.575 |
58 | Hypertrophic cardiomyopathy | 1.500 |
90 | Retinitis pigmentosa | 1.487 |
229 | Autoimmune pulmonary alveolar proteinosis | 1.365 |
172 | Hypophosphatasia | 1.365 |
127 | Frontotemporal lobar degeneration | 1.146 |
235 | Hypoparathyroidism | 1.048 |
137 | Focal cortical dysplasia | 1.000 |
192 | Cockayne syndrome | 1.000 |
277 | Lymphangiomatosis | 1.000 |
281 | Klippel-Trenaunay-Weber syndrome | 1.000 |
317 | Trifunctional protein deficiency | 1.000 |
52 | Mixed connective tissue disease | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |